Peptides DB
Research-centric peptide and protocol reference hub

Evuzamitide record · updated 13h ago

Healing & recoveryGrade A · human clinicalResearch use only
All 7 studiesJump to the evidenceCompare
What is Evuzamitide used for?

Research peptide discovered via AI researcher. peptide-based therapeutic

Primarily researched for · Healing & recovery

Development stage

where Evuzamitide sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 42 registered trials. It describes the research record, not a recommendation.

Identity
NameEvuzamitide
Chain length
Molecular weight
Formula
Structure type
ClassHealing
Research levelLimited Research
Discovered byThe Librarian · 2026
Pharmacology
Mechanism
Route
Half-life
Time to peak
Duration
Extraction confidence
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Aug 13, 2026. How this works →
Research stats
Total studies7
Human / animal / cellular4 / 0 / 1
Highest trial phasePreclinical
Years covered2026
Latest study20h ago
Publication history
20262026
Research funding
2 NIH projects · $1.4M awarded · through FY2026
Public grants naming this compound. Funding is interest, not evidence.
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work
Community reports
Positive Neutral Negative
Records

Study register

7 rowsOpen in the library →
StudyTypeYearSummary depth
Supporting change in a complex reality: a qualitative study of specialist nurses' perceptions of counselling patients at risk of type 2 diabetes.
TakeawaySpecialist nurses face significant barriers in providing effective dietary counselling for diabetes prevention, highlighting the need for better organizational support and cultural competence training.
Human2026Full text read0.80
Mimic antibodies: leveraging ligand mimicry for epitope-targeted antibody discovery.
Finding11 of 31 candidates bound the IL-18RA D3 domain, with eight achieving sub-nanomolar affinities.
In vitro2026Full text read0.80
Training and supervision of lay mental health workers in community-based interventions in East Africa: a scoping review.
FindingNot reported in abstract.
review2026Full text read0.70
Early and mature <i>Achromobacter xylosoxidans</i> biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics.
FindingNot reported in abstract.
Human2026Full text read0.80
Longitudinal symptom dynamics in postoperative patients with liver cancer: A cross-lagged panel network analysis.
FindingJaundice predicted vomiting (OR = 1.94, 95% CI [1.70, 2.14]) from T1 to T2.
Human2026Full text read0.90
Evaluating AI in postoperative rehabilitation of axillary web syndrome after breast cancer surgery: ChatGPT vs DeepSeek.
FindingDeepSeek performed significantly better than ChatGPT in diagnostic accuracy (p=0.006).
review2026Full text read0.80
Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of (124)I-evuzamitide to diagnose cardiac amyloidosis.
FindingNot reported in abstract.
Human2026Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Evuzamitide will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Evuzamitide is discussed should be drawn from it.